Vera Therapeutics (VERA) PT Lowered to $80 at Goldman Sachs

August 12, 2026 4:29 PM

Goldman Sachs analyst Paul Choi lowered the price target on Vera Therapeutics (NASDAQ: VERA) to $80.00 (from $90.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found